NCT06764264 is a clinical trial in Exertional Heat Injury, sponsored by Medical Corps, Israel Defense Force.

Who is sponsoring NCT06764264?

NCT06764264 is sponsored by Medical Corps, Israel Defense Force.

What condition does NCT06764264 study?

NCT06764264 studies Exertional Heat Injury.

Is NCT06764264 still recruiting?

NCT06764264 is currently completed. Last updated 8 January 2025.

Last reviewed 2025-01-08 · How we verify

NCT06764264

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Integrating Cognitive Assessments Into the Heat Tolerance Test After Exertional Heat Injury

Completed Last updated 8 January 2025

What this trial tests

trial in Exertional Heat Injury in 70 participants. Completed in 21 December 2024.

Timeline

1 February 2018

Primary endpoint
21 December 2024

21 December 2024

Quick facts

Lead sponsor	Medical Corps, Israel Defense Force
Status	Completed
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 February 2018
Primary completion	21 December 2024
Estimated completion	21 December 2024
Sites	1 location across Israel

Conditions studied

Exertional Heat Injury — all drugs for Exertional Heat Injury →

Sponsor

Medical Corps, Israel Defense Force — full company profile →

Who can join

18 and older, male only, with Exertional Heat Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational study is to evaluate soldiers post-exertional heat injury (EHI) during a heat tolerant test (HTT) to investigate the impact on their cognitive performance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Integrating Cognitive and Mood Assessments into the Heat Tolerance Test for Male Soldiers After Exertional Heat Injury: A Prospective Observational Study.
Erez D, Lieberman HR, Segev S, Izhaki Z, et al · · 2025 · PMID 41269435 · DOI 10.1186/s40798-025-00941-7

Verify or expand the search:

Other Medical Corps, Israel Defense Force trials

Trials by the same sponsor.

NCT07473362 — Hyperbaric Oxygen Therapy for Post Traumatic Stress Disorder - a Pragmatic, Double Blinded Randomized Trial · NA · recruiting
NCT06045481 — Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever · NA · not yet recruiting
NCT06123104 — Assessment of Automatic Tourniquets for Soldiers During Wartime · NA · unknown
NCT04482998 — Efficacy of Various Treatments for Acute Acoustic Trauma. · unknown
NCT04482985 — Meclizine Plasma Levels in Responders and Non-responders · Phase 4 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06764264 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical Corps, Israel Defense Force
Last refreshed: 8 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06764264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing